Market Place
Sourcing Support
Super`s Diana Fails EDQM inspection
06 Feb 2025 //
EMA
Enforcement Report - Week of February 5, 2025
05 Feb 2025 //
FDA
Center for Instrumental Analysis Receives FDA Warning Letter
04 Feb 2025 //
FDA
Shantou Kangjie Receives FDA Warning Letter
04 Feb 2025 //
FDA
Global Calcium Receives FDA Warning Letter
04 Feb 2025 //
FDA
Imperial Palace Commodity Receives FDA Warning Letter
04 Feb 2025 //
FDA
Alvogen Issues Voluntary Nationwide Recall for Fentanyl Transdermal
31 Jan 2025 //
FDA
Enforcement Report - Week of January 29, 2025
29 Jan 2025 //
FDA
Kardesler Ucan Yaglar Receives FDA Warning Letter
28 Jan 2025 //
FDA
Chara Biologics Receives FDA Warning Letter
28 Jan 2025 //
FDA
Evolutionary Biologics Receives FDA Warning Letter
28 Jan 2025 //
FDA
Wuhu Nuowei Chemistry is on FDA Import Alert List
24 Jan 2025 //
FDA
Provepharm Issues Voluntary Nationwide Recall of Phenylephrine
24 Jan 2025 //
FDA
Enforcement Report - Week of January 22, 2025
22 Jan 2025 //
FDA
Atlanta Supersource Receives FDA Warning Letter
21 Jan 2025 //
FDA
Sanofi Receives FDA Warning Letter
21 Jan 2025 //
FDA
Aspen Biopharma Labs is on FDA Import Alert List
15 Jan 2025 //
FDA
Enforcement Report - Week of January 15, 2025
15 Jan 2025 //
FDA
FDA Issues Form 483 to Zhejiang Tianyu Pharma
14 Jan 2025 //
FDA
Health Canada Issues Recalls of Angita Pharma
13 Jan 2025 //
HEALTH CANADA
Maithili Life Sciences Fails EDQM inspection
13 Jan 2025 //
EMA
FDA Issues Form 483 to Hubei Gedian Humanwell Pharma
10 Jan 2025 //
FDA
FDA Issues Form 483 to Hubei Gedian Humanwell
10 Jan 2025 //
FDA
Jin Xiang Nongyuan Formulation India is on FDA Import Alert List
08 Jan 2025 //
FDA
FDA Issues Other Correspondence to Aptar Radolfzell
08 Jan 2025 //
FDA
Enforcement Report - Week of January 8, 2025
08 Jan 2025 //
FDA
Health Canada Issues Recalls of Sivem Pharma
07 Jan 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Jamp Pharma
07 Jan 2025 //
HEALTH CANADA
Indoco Receives FDA Warning Letter
07 Jan 2025 //
FDA
FDA Issues Form 483 to Mylan Laboratories Ltd
03 Jan 2025 //
FDA
Tyche Industries Formulation India is on FDA Import Alert List
02 Jan 2025 //
FDA
Enforcement Report - Week of January 1, 2025
01 Jan 2025 //
FDA
Bhargava Phytolab Receives FDA Warning Letter
31 Dec 2024 //
FDA
Health Canada Issues Recalls of Pharmascience
30 Dec 2024 //
HEALTH CANADA
Enforcement Report - Week of December 25, 2024
25 Dec 2024 //
FDA
Sombra Cosmetics Receives FDA Warning Letter
24 Dec 2024 //
FDA
Viatris Receives FDA Warning Letter
24 Dec 2024 //
FDA
Akron Formulations Receives FDA Warning Letter
24 Dec 2024 //
FDA
Astellas Issues Voluntary Nationwide Recall of Prograf
24 Dec 2024 //
FDA
Brands International Receives FDA Warning Letter
24 Dec 2024 //
FDA
Alcon Lab Issues Voluntary Nationwide Recall of Systane
23 Dec 2024 //
FDA
Health Canada Issues Recall of Jamp Pharma
23 Dec 2024 //
HEALTH CANADA
FDA Issues Form 483 to Biotika AS
19 Dec 2024 //
FDA
Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee
18 Dec 2024 //
FDA
Enforcement Report - Week of December 18, 2024
18 Dec 2024 //
FDA
Micro Orgo Chem Receives FDA Warning Letter
17 Dec 2024 //
FDA
GNMART Inc Issues Voluntary Nationwide Recall of Force Forever
16 Dec 2024 //
FDA
Enforcement Report - Week of December 11, 2024
11 Dec 2024 //
FDA
Dr. Brite, LLC Receives FDA Warning Letter
10 Dec 2024 //
FDA
Guangzhou Four E’s Scientific Receives FDA Warning Letter
10 Dec 2024 //
FDA
FDA Issues Form 483 to Fresenius Kabi Oncology Limited
05 Dec 2024 //
FDA
Enforcement Report - Week of December 4, 2024
04 Dec 2024 //
FDA
Zhejiang Uniquality Receives FDA Warning Letter
03 Dec 2024 //
FDA
Applied Therapeutics Receives FDA Warning Letter
03 Dec 2024 //
FDA
FDA Issues Form 483 to Patheon Italia S.p.A
27 Nov 2024 //
FDA
Enforcement Report - Week of November 27, 2024
27 Nov 2024 //
FDA
FDA Issues Form 483 to Apicore Pharmaceuticals
26 Nov 2024 //
FDA
Akron Formulation India is on FDA Import Alert List
26 Nov 2024 //
FDA
Hangzhou Huiji Biotech Receives FDA Warning Letter
26 Nov 2024 //
FDA
Catwalk Cosmetic Lab Biotech Receives FDA Warning Letter
26 Nov 2024 //
FDA
